Structural and functional studies of the ganglisoide binding activities of tetanus toxin

Structural and functional studies of the ganglisoide binding activities of tetanus toxin

Detalhes bibliográficos
Principais autores:	Fairweather, N, Sinha, K, Black, I, Emsley, P, Fotinou, C, Isaacs, N
Formato:	Journal article
Publicado em:	2002

Registros relacionados

The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding.
por: Emsley, P, et al.
Publicado em: (2000)

The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.
por: Fotinou, C, et al.
Publicado em: (2001)

Tetanus.
por: Farrar, J, et al.
Publicado em: (2000)

Tetanus toxin: importance and characteristic
por: Heidi Celina Oviedo Acevedo, et al.
Publicado em: (1999-04-01)

The HC fragment of tetanus toxin forms stable, concentration-dependent dimers via an intermolecular disulphide bond.
por: Qazi, O, et al.
Publicado em: (2007)

Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test
por: Denise Cristina Souza Matos, et al.
Publicado em: (2002-09-01)

How does tetanus toxin act?
por: Mellanby, J, et al.
Publicado em: (1981)

Study of the tetanus toxin production by fermentation
por: J. Quintero, et al.
Publicado em: (2011-12-01)

Tetanus toxin as a tool for studying epilepsy.
por: Mellanby, J, et al.
Publicado em: (1984)

Tetanus Toxin C-Fragment: The Courier and the Cure?
por: Rosario Osta, et al.
Publicado em: (2010-10-01)

Updates on tetanus toxin: a fundamental approach
por: Md. Ahaduzzaman
Publicado em: (2015-03-01)

Botulinum toxin A for trismus in cephalic tetanus
por: Luiz Augusto F. Andrade, et al.
Publicado em: (1994-09-01)

Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production
por: Caroline Bayart, et al.
Publicado em: (2022-06-01)

Structural basis of tetanus toxin neutralization by native human monoclonal antibodies
por: Yueming Wang, et al.
Publicado em: (2021-05-01)

Tetanus: Pathophysiology, Treatment, and the Possibility of Using Botulinum Toxin against Tetanus-Induced Rigidity and Spasms
por: Bjørnar Hassel
Publicado em: (2013-01-01)

The monoclonal antibody 26 raised against tetanus toxoid also recognizes tetanus toxin and b2-glycoprotein I – its binding properties in vitro and potential applications
por: ALEKSANDRA B. INIĆ-KANADA, et al.
Publicado em: (2009-03-01)

The monoclonal antibody 26 raised against tetanus toxoid also recognizes tetanus toxin and β2-glycoprotein I - its binding properties in vitro and potential applications
por: Inić-Kanada Aleksandra B., et al.
Publicado em: (2009-01-01)

Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test
por: M.H. Sonobe, et al.
Publicado em: (2007-01-01)

Modeling the Interictal Epileptic State for Therapeutic Development with Tetanus Toxin
por: Faezeh Eslami, et al.
Publicado em: (2024-06-01)

Predicting the clinical outcome of tetanus: the tetanus severity score.
por: Thwaites, C, et al.
Publicado em: (2006)

Is there retrograde axonal transport of tetanus toxin in both alpha and beta fibres?
por: Green, J, et al.
Publicado em: (1977)

Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
por: Kexuan Cheng, et al.
Publicado em: (2024-12-01)

Confocal Endomicroscopy of Neuromuscular Junctions Stained with Physiologically Inert Protein Fragments of Tetanus Toxin
por: Cornelia Roesl, et al.
Publicado em: (2021-10-01)

Dynamic multiday seizure cycles and evolving rhythms in a tetanus toxin rat model of epilepsy
por: Parvin Zarei Eskikand, et al.
Publicado em: (2025-02-01)

In Silico Modeling and Production of New Vaccine Consisting of E7 Antigen Conjugated with Tetanus Toxin
por: M Jokar, et al.
Publicado em: (2017-01-01)

Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model
por: Laura Moreno-Martinez, et al.
Publicado em: (2020-05-01)

LOW DOSE TETANUS TOXIN INJECTIONS INTO THE RAT BASAL GANGLIA IMPAIR MOTOR PERFORMANCE
por: Patrik Meglić, et al.
Publicado em: (2023-10-01)

Tetanus toxin fragments and Bcl-2 fusion proteins: cytoprotection and retrograde axonal migration
por: Yasuhiro Watanabe, et al.
Publicado em: (2018-06-01)

Urinary catecholamine excretion in tetanus.
por: Thwaites, C, et al.
Publicado em: (2006)

Intrathecal serotherapy of tetanus. I. Explanation of complications. II. Comparison of intrathecal tetanus immune globulin and tetanus antitoxin
por: I Ildirim
Publicado em: (1974-07-01)

Tetanus
por: Thwaites, G, et al.
Publicado em: (2012)

Maternal and neonatal tetanus.
por: Thwaites, C, et al.
Publicado em: (2015)

Ocular tetanus
por: Muddappa T, et al.
Publicado em: (1982-01-01)

Penggunaan Anti Tetanus Serum dan Human Tetanus Immunoglobulin pada Tetanus Anak
por: Martinus M. Leman, et al.
Publicado em: (2016-11-01)

The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity
por: Rui Yu, et al.
Publicado em: (2020-01-01)

Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease
por: Mireia Herrando-Grabulosa, et al.
Publicado em: (2020-10-01)

Tetanus Toxin <italic toggle="yes">cis</italic>-Loop Contributes to Light-Chain Translocation
por: Madison Zuverink, et al.
Publicado em: (2020-06-01)

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine
por: C. Panpitpat, et al.
Publicado em: (2000-03-01)

Structural basis of pore formation by cholesterol-binding toxins
por: Gilbert, R, et al.
Publicado em: (2000)

Structural basis of pore formation by cholesterol-binding toxins.
por: Gilbert, R, et al.
Publicado em: (2000)